157 related articles for article (PubMed ID: 21135144)
1. Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort.
Sun T; Mary LG; Oh WK; Freedman ML; Pomerantz M; Pienta KJ; Kantoff PW
Clin Cancer Res; 2011 Mar; 17(6):1546-52. PubMed ID: 21135144
[TBL] [Abstract][Full Text] [Related]
2. Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population.
Sun T; Lee GS; Oh WK; Pomerantz M; Yang M; Xie W; Freedman ML; Kantoff PW
Clin Cancer Res; 2010 Nov; 16(21):5244-51. PubMed ID: 20855462
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of chemokine CCL2 and chemokine receptor CCR2 genes and risk of prostate cancer.
Mandal RK; Agrawal T; Mittal RD
Tumour Biol; 2015 Jan; 36(1):375-81. PubMed ID: 25266801
[TBL] [Abstract][Full Text] [Related]
4. Association of a TFAM haplotype with aggressive prostate cancer in overweight or obese Mexican Mestizo men.
Granados JB; Méndez JP; Feria-Bernal G; García-García E; Tejeda ME; Rojano-Mejía D; Tapia A; Canto P
Urol Oncol; 2017 Mar; 35(3):111.e9-111.e14. PubMed ID: 27843028
[TBL] [Abstract][Full Text] [Related]
5. Association between CCL2 haplotypes and knee osteoarthritis.
Hulin-Curtis SL; Bidwell JL; Perry MJ
Int J Immunogenet; 2013 Aug; 40(4):280-3. PubMed ID: 23211090
[TBL] [Abstract][Full Text] [Related]
6. The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.
Sun T; Oh WK; Jacobus S; Regan M; Pomerantz M; Freedman ML; Lee GS; Kantoff PW
Cancer Prev Res (Phila); 2011 Dec; 4(12):2044-50. PubMed ID: 21900597
[TBL] [Abstract][Full Text] [Related]
7. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
[TBL] [Abstract][Full Text] [Related]
8. Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality.
Pomerantz MM; Werner L; Xie W; Regan MM; Lee GS; Sun T; Evan C; Petrozziello G; Nakabayashi M; Oh WK; Kantoff PW; Freedman ML
Cancer Prev Res (Phila); 2011 May; 4(5):719-28. PubMed ID: 21367958
[TBL] [Abstract][Full Text] [Related]
9. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.
Cheng I; Stram DO; Penney KL; Pike M; Le Marchand L; Kolonel LN; Hirschhorn J; Altshuler D; Henderson BE; Freedman ML
J Natl Cancer Inst; 2006 Jan; 98(2):123-34. PubMed ID: 16418515
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Role of C-C Motif Chemokine Ligand-2 Single Nucleotide Polymorphism in Pulmonary Tuberculosis: A Genetic Association Study from North India.
Biswas SK; Mittal M; Sinha E; Singh V; Arela N; Bajaj B; Tiwari PK; Katoch VM; Mohanty KK
J Immunol Res; 2020; 2020():1019639. PubMed ID: 33381602
[TBL] [Abstract][Full Text] [Related]
11. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
[TBL] [Abstract][Full Text] [Related]
12. Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects.
Viladés C; Broch M; Plana M; Domingo P; Alonso-Villaverde C; Pedrol E; Knobel H; Dalmau D; Peraire J; Gutiérrez C; López A; Sambeat MA; Olona M; Garcia F; Richart C; Gatell JM; Vidal F;
J Acquir Immune Defic Syndr; 2007 Feb; 44(2):132-8. PubMed ID: 17091019
[TBL] [Abstract][Full Text] [Related]
13. Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.
Han JH; Lee YS; Kim HJ; Lee SY; Myung SC
Asian J Androl; 2015; 17(2):285-91. PubMed ID: 25337833
[TBL] [Abstract][Full Text] [Related]
14. CD24 is a genetic modifier for risk and progression of prostate cancer.
Zhang Y; Li B; Zhang X; Sonpavde GP; Jiao K; Zhang A; Zhang G; Sun M; Chu C; Li F; Wang L; Cui R; Liu R
Mol Carcinog; 2017 Feb; 56(2):641-650. PubMed ID: 27377469
[TBL] [Abstract][Full Text] [Related]
15. Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy.
Sun T; Lee GS; Werner L; Pomerantz M; Oh WK; Kantoff PW; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1871-8. PubMed ID: 20615892
[TBL] [Abstract][Full Text] [Related]
16. Mutation screen and association study of EZH2 as a susceptibility gene for aggressive prostate cancer.
Bachmann N; Hoegel J; Haeusler J; Kuefer R; Herkommer K; Paiss T; Vogel W; Maier C
Prostate; 2005 Nov; 65(3):252-9. PubMed ID: 16015586
[TBL] [Abstract][Full Text] [Related]
17. Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis.
Carulli MT; Spagnolo P; Fonseca C; Welsh KI; duBois RM; Black CM; Denton CP
J Rheumatol; 2008 May; 35(5):839-44. PubMed ID: 18381789
[TBL] [Abstract][Full Text] [Related]
18. Association of prostate cancer risk variants with clinicopathologic characteristics of the disease.
Xu J; Isaacs SD; Sun J; Li G; Wiley KE; Zhu Y; Hsu FC; Wiklund F; Turner AR; Adams TS; Liu W; Trock BJ; Partin AW; Chang B; Walsh PC; Grönberg H; Isaacs W; Zheng S
Clin Cancer Res; 2008 Sep; 14(18):5819-24. PubMed ID: 18794092
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in DKK3 gene are associated with prostate cancer risk and progression.
Kim MS; Lee HN; Kim HJ; Myung SC
Int Braz J Urol; 2015; 41(5):869-97. PubMed ID: 26689513
[TBL] [Abstract][Full Text] [Related]
20. Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.
Batra J; Lose F; O'Mara T; Marquart L; Stephens C; Alexander K; Srinivasan S; Eeles RA; Easton DF; Al Olama AA; Kote-Jarai Z; Guy M; Muir K; Lophatananon A; Rahman AA; Neal DE; Hamdy FC; Donovan JL; Chambers S; Gardiner RA; Aitken J; Yaxley J; Kedda MA; Clements JA; Spurdle AB
PLoS One; 2011; 6(11):e26527. PubMed ID: 22132073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
